From the Journals

RV dysfunction slams survival in acute COVID, flu, pneumonia


 

Limitations

  • The study was based primarily on a retrospective review of electronic health records, which poses a risk for misclassification.
  • Echocardiography was performed without blinding operators to patient clinical status, and echocardiograms were interpreted in a single university hospital system, so were not externally validated.
  • Because echocardiograms obtained during hospitalization could not be compared with previous echocardiograms, it could not be determined whether any of the patients had preexisting RV dilation or dysfunction.
  • Strain imaging was not feasible in many cases.

Disclosures

  • The study received no commercial funding.
  • The authors disclosed no financial relationships.

This is a summary of a preprint research study, Association of Right Ventricular Dilation and Dysfunction on Echocardiogram With In-Hospital Mortality Among Patients Hospitalized with COVID-19 Compared With Other Acute Respiratory Illness, written by researchers at the University of California, San Francisco, department of medicine, and Zuckerberg San Francisco General Hospital, division of cardiology. A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

U.S. allows pharmacists to prescribe Paxlovid directly
MDedge Internal Medicine
‘Myriad’ dermatologic reactions after COVID-19 vaccination
MDedge Internal Medicine
Obesity links to faster fading of COVID vaccine protection
MDedge Internal Medicine
BA.4 and BA.5 subvariants are more evasive of antibodies, but not of cellular immunity
MDedge Internal Medicine
FDA grants emergency authorization for Novavax COVID vaccine
MDedge Internal Medicine
Shift schedule today could worsen that stroke tomorrow
MDedge Internal Medicine
Some have heavier periods after COVID vaccine
MDedge Internal Medicine
Cancer drug significantly cuts risk for COVID-19 death
MDedge Internal Medicine
Many people becoming reinfected as BA.5 dominates new COVID-19 cases
MDedge Internal Medicine
Methotrexate’s impact on COVID-19 vaccination: New insights made
MDedge Internal Medicine